Stock Scorecard



Stock Summary for ASP Isotopes Inc (ASPI) - $6.98 as of 7/3/2025 8:50:44 PM EST

Total Score

6 out of 30

Safety Score

17 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ASPI

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ASPI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ASPI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ASPI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ASPI (17 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ASPI

Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status - ASP Isotopes ( NASDAQ:ASPI ) , Chart Industries ( NYSE:GTLS ) 6/18/2025 2:11:00 PM
Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status 6/18/2025 2:11:00 PM
ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC ( QLE ) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE - ASP Isotopes ( NASDAQ:ASPI ) 6/11/2025 12:23:00 PM
ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC ( QLE ) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE 6/11/2025 12:23:00 PM
ASP Isotopes Inc. to host Investor Access Event in South Africa from June 16-18, 2025 6/4/2025 1:00:00 PM
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies 6/4/2025 12:30:00 PM
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies - ASP Isotopes ( NASDAQ:ASPI ) 6/4/2025 12:30:00 PM
ASP Isotopes Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock 6/2/2025 1:15:00 PM
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies - ASP Isotopes ( NASDAQ:ASPI ) 6/2/2025 1:00:00 PM
ASP Isotopes Issues Letter to Shareholders 5/29/2025 12:11:00 PM

Financial Details for ASPI

Company Overview

Ticker ASPI
Company Name ASP Isotopes Inc
Country USA
Description Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.
Sector Name LIFE SCIENCES
Industry Name MISCELLANEOUS CHEMICAL PRODUCTS
Most Recent Quarter 3/31/2025
Next Earnings Date 9/3/2025

Stock Price History

Last Day Price 6.98
Price 4 Years Ago 0.00
Last Day Price Updated 7/3/2025 8:50:44 PM EST
Last Day Volume 1,207,166
Average Daily Volume 4,381,242
52-Week High 10.08
52-Week Low 1.86
Last Price to 52 Week Low 275.27%

Valuation Measures

Trailing PE N/A
Industry PE 24.98
Sector PE 40.90
5-Year Average PE -24.11
Free Cash Flow Ratio 10.42
Industry Free Cash Flow Ratio 31.12
Sector Free Cash Flow Ratio 32.91
Current Ratio Most Recent Quarter 7.21
Total Cash Per Share 0.67
Book Value Per Share Most Recent Quarter 0.59
Price to Book Ratio 13.87
Industry Price to Book Ratio 4.11
Sector Price to Book Ratio 30.76
Price to Sales Ratio Twelve Trailing Months 133.84
Industry Price to Sales Ratio Twelve Trailing Months 2.11
Sector Price to Sales Ratio Twelve Trailing Months 35.60
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 83,875,000
Market Capitalization 585,447,500
Institutional Ownership 43.84%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -98.53%
Reported EPS 12 Trailing Months -0.59
Reported EPS Past Year -0.12
Reported EPS Prior Year -0.62
Net Income Twelve Trailing Months -33,831,693
Net Income Past Year -32,333,581
Net Income Prior Year -16,286,234
Quarterly Revenue Growth YOY 31.10%
5-Year Revenue Growth -34.58%
Operating Margin Twelve Trailing Months -722.00%

Balance Sheet

Total Cash Most Recent Quarter 55,965,443
Total Cash Past Year 61,890,048
Total Cash Prior Year 7,908,181
Net Cash Position Most Recent Quarter 20,115,150
Net Cash Position Past Year 27,015,578
Long Term Debt Past Year 34,874,470
Long Term Debt Prior Year 10,000
Total Debt Most Recent Quarter 35,850,293
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.54
Total Stockholder Equity Past Year 47,898,492,000,000
Total Stockholder Equity Prior Year 16,295,953
Total Stockholder Equity Most Recent Quarter 42,512,697

Free Cash Flow

Free Cash Flow Twelve Trailing Months -29,380,814
Free Cash Flow Per Share Twelve Trailing Months -0.35
Free Cash Flow Past Year -28,067,760
Free Cash Flow Prior Year -7,743,735

Options

Put/Call Ratio 0.09
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.06
MACD Signal 0.11
20-Day Bollinger Lower Band 3.00
20-Day Bollinger Middle Band 6.16
20-Day Bollinger Upper Band 9.31
Beta 3.59
RSI 44.78
50-Day SMA 5.12
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 7/4/2025 1:16:52 AM EST